Olimel Periferico N4e

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel Periferico N4e, is a mixture of essential and non‑essential amino acids presented as a sterile powder for intravenous use. It supports metabolic functions and protein synthesis in patients requiring nutritional supplementation.

GNH USA supplies Olimel Periferico N4e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Olimel Periferico N4e provides an amino‑acid solution for patients with increased metabolic demand or protein loss. It is used in: - Post‑operative recovery: helps maintain nitrogen balance and supports tissue repair. - Severe trauma or burns: supplies essential amino acids needed for wound healing. - Chronic kidney disease on dialysis : assists in preventing malnutrition and muscle wasting. - Long‑term parenteral nutrition: provides a balanced amino‑acid profile for patients who cannot receive enteral feeding. - Critical‑care intensive care unit (ICU) patients: contributes to overall nutritional support. - Metabolic disorders : aids in correcting specific amino‑acid deficiencies.

Amino‑acid solutions may cause infusion‑related reactions, which vary in frequency and severity.

Common Side Effects: - Mild nausea: transient discomfort during or after infusion. - Transient headache: brief headache that resolves without intervention. - Low‑grade fever: mild temperature rise during treatment. - Local irritation: redness or warmth at the infusion site. - Electrolyte shift: minor changes in serum electrolytes. - Hyperglycaemia: temporary rise in blood glucose levels.

Serious or Rare Side Effects: - Anaphylactic reaction: sudden, severe allergic response requiring emergency care. - Severe hypotension: marked drop in blood pressure during infusion. - Metabolic acidosis: significant disturbance in acid‑base balance. - Thrombophlebitis: inflammation of a vein with clot formation. - Acute renal impairment: sudden decline in kidney function. - Seizure activity: rare neurologic event linked to metabolic imbalance.

When using Olimel Periferico N4e, clinicians should consider several safety measures.

- Assess renal function: evaluate baseline creatinine and glomerular filtration rate. - Monitor electrolytes: check serum sodium, potassium, and calcium regularly. - Observe infusion site: watch for signs of phlebitis or infiltration. - Adjust for liver disease: reduce dose if hepatic impairment is present. - Use aseptic technique: maintain sterility throughout preparation and administration. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Olimel Periferico N4e may interact with other agents administered intravenously.

Major Interactions (Avoid): - Concurrent high‑dose potassium chloride: may cause dangerous hyper‑kalemia. - Acidic intravenous solutions: can precipitate amino acids, reducing efficacy.

Moderate Interactions (Monitor Closely): - Diuretics: may amplify electrolyte disturbances. - Insulin therapy: heightened risk of hypoglycaemia when combined with hyperglycaemic effect of the amino‑acid mix. - Anticoagulants: potential alteration of coagulation parameters. - Parenteral lipid emulsions: may affect the stability of the amino‑acid solution. - Other parenteral nutrition components: require compatibility checks.